BFK — Pharmesis International Balance Sheet
0.000.00%
Last trade - 00:00- SG$3.06m
- SG$4.96m
- CNY45.64m
Annual balance sheet for Pharmesis International, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 14.7 | 15.2 | 14 | 19.7 | 9.48 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 17.1 | 12.7 | 14.2 | 12.9 | 8.31 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 38.9 | 37 | 37.1 | 44.2 | 33.3 |
| Net Property, Plant And Equipment | 53.7 | 51.8 | 53.1 | 51.3 | 50.2 |
| Net Goodwill | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 93.9 | 91.3 | 92.7 | 97.9 | 85.9 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 29.2 | 32.4 | 30.8 | 39.6 | 30.6 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Liabilities | 31.8 | 35 | 35.2 | 44 | 34.8 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 62.1 | 56.3 | 57.5 | 53.9 | 51.1 |
| Total Liabilities & Shareholders' Equity | 93.9 | 91.3 | 92.7 | 97.9 | 85.9 |
| Total Common Shares Outstanding |